title: [Beta-blockers and plasma lipids].
abstract: Beta-blockers are frequently used in the treatment of hypertension. However their long term use has been associated with an increase of serum triglycerides and a decrease of HLD-cholesterol concentrations which could diminish the benefit drawn from their hypotensive effect. The effect on lipid metabolism is less unfavourable when beta-blockers exert an intrinsic sympathomimetic activity or are said to be cardioselective. Mechanisms involved are complex and poorly understood.
authors.affiliation: Service de Pharmacologie-Toxicologie, Hôpital Dupuytren, Limoges.
authors.forename: C
authors.initials: C
authors.lastname: Soulier
authors.forename: L
authors.initials: L
authors.lastname: Merle
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000145:classification / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D008055:Lipids / Q000097:blood*; D013997:Time Factors
chemical_list: D000319:Adrenergic beta-Antagonists; D008055:Lipids
vernacular_title: Bêta-bloquants et lipides plasmatiques.